
Amoxycillin (500mg) + Clavulanic Acid (125mg)
Active composition
+1 more active ingredient
Amoxycillin inhibits the synthesis of peptidoglycan in bacterial cell walls, leading to cell lysis and death.
Medical applications
Moxidoz-CV 625 Tablet is a fixed-dose combination antibiotic tablet containing amoxicillin 500mg and clavulanic acid 125mg. This product is indicated for the treatment of bacterial infections such as upper respiratory tract infections, otitis media, and sinusitis. Amoxicillin, a semi-synthetic penicillin, inhibits bacterial cell wall synthesis, thereby preventing bacterial growth and proliferation. Clavulanic acid, an β-lactamase inhibitor, prevents the inactivation of amoxicillin by β-lactamase enzymes, thereby enhancing the antibacterial activity of amoxicillin. The combination of amoxicillin and clavulanic acid provides a broad-spectrum antibacterial effect against both gram-positive and gram-negative bacteria, including organisms producing β-lactamase enzymes. Moxidoz-CV 625 Tablet is available in a once-daily dosage regimen, making it a convenient treatment option for patients with bacterial infections. Its efficacy and safety profile have been established in a wide range of patient populations, including pediatric and adult patients.
How to use Moxidoz-CV Tablet Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Moxidoz-CV 625 Tablet is to be taken with food.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
It is not known whether it is safe to consume alcohol with Moxidoz-CV 625 Tablet. Please consult your doctor.
High Risk
Moxidoz-CV 625 Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Medical Advice
Moxidoz-CV 625 Tablet may cause side effects which could affect your ability to drive. Moxidoz-CV 625 Tablet may cause side effects such as allergic reactions, dizziness, or fits that may make you unfit to drive.
Exercise Caution
Moxidoz-CV 625 Tablet should be used with caution in patients with liver disease. Dose adjustment of Moxidoz-CV 625 Tablet may be needed. Please consult your doctor. Regular monitoring of liver function tests is recommended while you are taking this medicine
Regular Checkup
Moxidoz-CV 625 Tablet should be used with caution during breastfeeding. Breastfeeding should be held until the treatment of the mother is completed and the drug is eliminated from her body.
Consult Doctor
Moxidoz-CV 625 Tablet should be used with caution in patients with kidney disease. Dose adjustment of Moxidoz-CV 625 Tablet may be needed. Please consult your doctor. Use of this medicine is not recommended in patients with severe kidney disease.
Regular Checkup
0 reviews for Moxidoz-CV 625 Tablet

Amoxycillin (500mg) + Clavulanic Acid (125mg)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
+1 more active ingredient
Amoxycillin inhibits the synthesis of peptidoglycan in bacterial cell walls, leading to cell lysis and death.
Medical applications
Moxidoz-CV 625 Tablet is a fixed-dose combination antibiotic tablet containing amoxicillin 500mg and clavulanic acid 125mg. This product is indicated for the treatment of bacterial infections such as upper respiratory tract infections, otitis media, and sinusitis. Amoxicillin, a semi-synthetic penicillin, inhibits bacterial cell wall synthesis, thereby preventing bacterial growth and proliferation. Clavulanic acid, an β-lactamase inhibitor, prevents the inactivation of amoxicillin by β-lactamase enzymes, thereby enhancing the antibacterial activity of amoxicillin. The combination of amoxicillin and clavulanic acid provides a broad-spectrum antibacterial effect against both gram-positive and gram-negative bacteria, including organisms producing β-lactamase enzymes. Moxidoz-CV 625 Tablet is available in a once-daily dosage regimen, making it a convenient treatment option for patients with bacterial infections. Its efficacy and safety profile have been established in a wide range of patient populations, including pediatric and adult patients.
How to use Moxidoz-CV Tablet Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Moxidoz-CV 625 Tablet is to be taken with food.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
It is not known whether it is safe to consume alcohol with Moxidoz-CV 625 Tablet. Please consult your doctor.
High Risk
Moxidoz-CV 625 Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Medical Advice
Moxidoz-CV 625 Tablet may cause side effects which could affect your ability to drive. Moxidoz-CV 625 Tablet may cause side effects such as allergic reactions, dizziness, or fits that may make you unfit to drive.
Exercise Caution
Moxidoz-CV 625 Tablet should be used with caution in patients with liver disease. Dose adjustment of Moxidoz-CV 625 Tablet may be needed. Please consult your doctor. Regular monitoring of liver function tests is recommended while you are taking this medicine
Regular Checkup
Moxidoz-CV 625 Tablet should be used with caution during breastfeeding. Breastfeeding should be held until the treatment of the mother is completed and the drug is eliminated from her body.
Consult Doctor
Moxidoz-CV 625 Tablet should be used with caution in patients with kidney disease. Dose adjustment of Moxidoz-CV 625 Tablet may be needed. Please consult your doctor. Use of this medicine is not recommended in patients with severe kidney disease.
Regular Checkup
0 reviews for Moxidoz-CV 625 Tablet















